Skip to content
healthcare.dev
Get a free key

Vabrinty

NDC 85043-045, Leuprolide acetate, injection, suspension, extended release, from URONOVA PHARMACEUTICALS, INC..

Product NDC
85043-045
Status
Listed
Labeler
URONOVA PHARMACEUTICALS, INC.
Dosage form
INJECTION, SUSPENSION, EXTENDED RELEASE
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA021731
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/85043-045 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LEUPROLIDE ACETATE45 mg/.375mL

Pharmacologic classes

Gonadotropin Releasing Hormone Receptor Agonist [EPC]; Gonadotropin Releasing Hormone Receptor Agonists [MoA]

Package NDCNDC-11Package
85043-045-04850430045041 SYRINGE in 1 CARTON (85043-045-04) / .375 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/008776cc-83f1-4f8c-819b-6471425da15f

Use it

Look up 85043-045 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/85043-045 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 85043-045. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.